Perimeter Medical Imaging AI Launches OCT-Tissue Registry to Enhance Surgical AI Technology

Perimeter Medical Imaging AI ( (TSE:PINK) ) has shared an announcement.

Perimeter Medical Imaging AI has launched the OCT-Tissue Surveillance Registry to collect images and data from surgeries using their imaging technology. This initiative aims to enhance their AI deep-learning model for investigational technology, potentially improving surgical outcomes and reducing the need for second surgeries. The registry will help in developing a sophisticated AI model by gathering diverse data, which could lead to more personalized patient care and better clinical results.

The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$1.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Spark’s Take on TSE:PINK Stock

According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.

Perimeter Medical Imaging AI is positioned in a growth phase with strong revenue increases and promising clinical advancements towards FDA approval. However, persistent net losses, cash flow constraints, and bearish technical indicators pose significant challenges. The valuation remains unattractive, but recent strategic corporate events offer potential for future expansion.

To see Spark’s full report on TSE:PINK stock, click here.

More about Perimeter Medical Imaging AI

Perimeter Medical Imaging AI, Inc. is a medical technology company based in Toronto, Canada, and Dallas, Texas, focused on transforming cancer surgery through advanced imaging tools. Their FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The company is also developing the Perimeter B-Series OCT with ImgAssist AI, a next-generation technology aimed at improving breast-conserving surgeries.

Average Trading Volume: 88,783

Technical Sentiment Signal: Sell

Current Market Cap: C$21.51M

Learn more about PINK stock on TipRanks’ Stock Analysis page.